Abstract:P2 receptors mediate the actions of the extracellular nucleotides ATP, ADP, UTP, and UDP, regulating several physiologic responses including cardiac function, vascular tone, smooth muscle cell (SMC) proliferation, platelet aggregation, and the release of endothelial factors. P2 receptor characterization has been hampered by the lack of selective antagonists. The aim of the current study was to investigate the mRNA and protein expression of P2X and P2Y receptors in human SMC and in endothelial cells (EC). Smooth muscle cells were obtained from human mammary artery and EC from human umbilical vein. Using real-time PCR, the authors established quantitative mRNA assays. Protein expression was studied using Western blotting with recently developed antibodies. The P2X1 receptor was highly specific for human SMC, while the P2X4 was the highest expressed receptor in EC. The P2Y2 receptor was present in both SMC and EC. UTP-mediated effects in these cells are likely to be mediated by P2Y2 and not P2Y4 receptors since the latter had considerably lower expression. The P2Y6 receptor was expressed in both SMC and EC. The P2Y1 and surprisingly the P2Y11 receptors were the most abundantly expressed P2Y receptors in the endothelium. Overall, Western blotting confirmed the mRNA findings in most aspects, and most interestingly, indicated oligomerization of the P2Y1 receptor that may be important for its function. In conclusion, P2X1, P2Y2, and P2Y6 are the most expressed P2 receptors in SMC and are thus probably mediating the contractile and mitogenic actions of extracellular nucleotides. The P2X4, P2Y11, P2Y1, and P2Y2 are the most expressed P2 receptors in EC, and are most likely mediating release of nitric oxide, endothelium-dependent hyperpolarizing factor (EDHF), and t-PA induced by extracellular nucleotides. These findings will help to direct future cardiovascular drug development against the large P2 receptor family.

P2 Receptors in Blood Vessel and Its Relationship with Some Vascular Diseases

Function of P2 Receptors in Skeletal Muscle and Their Roles in the Diseases

P2 Purine Receptors and Cell Signal Transduction

Function of P2X Receptors in Viscera and Disease

The Role and Molecular Mechanism of P2Y12 Receptors in the Pathogenesis of Atherosclerotic Cardiovascular Diseases

P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells

Comprehensive Insights into Potential Roles of Purinergic P2 Receptors on Diseases: Signaling Pathways Involved and Potential Therapeutics

Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis

Molecular pharmacology of P2Y receptor subtypes

P2Y Receptors in Immune Response and Inflammation

Expression and Function of P2 Receptors in Hematopoietic Stem and Progenitor Cells.

The Role of P2Y6R in Cardiovascular Diseases and Recent Development of P2Y6R Antagonists

The P2X7 Purinergic Receptor: an Emerging Therapeutic Target in Cardiovascular Diseases

Blood cells: an historical account of the roles of purinergic signalling

The Interplay of Endothelial P2Y Receptors in Cardiovascular Health: From Vascular Physiology to Pathology

P2X and P2Y Receptors—Role in the Pathophysiology of the Nervous System

Function of P2 Receptors in Skeletal System and Inflammatory Disease of Bone

Recent Developments in Purinergic Receptors of Endocrine Pancreas

The P2X<sub>1</sub>ion channel in platelet function

Purinergic P2Y2 receptors mediate rapid Ca2+ mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells

P2 X7 receptor and renal diseases